Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
I don't think there is as much demand for a covid test as there was and by the time this is ready I really do think we will have missed the boat despite what Carl says. If you look at all the other covid stocks they have all gone done considerably although ODX is an expection as they are trying to raise money. The good news for us is CX300 can be used on sepsis and bladder cancer so hopefully they will have learned lessions along the way. With all the other investments in the portfolio this does look like a good buy in price. I'm down considerably on this investment but then I expect nearly everyone else is too. At least it looks like they have a plan and are flexible in there approach, no point flogging a dead horse.
If they can improve it's accuracy similar to PCR, and with it's results in minutes then airports would be the way to go. Hospitals, care homes and hospitality might be interested too. Not long to wait now! Should know by the middle of March at the latest.
My point was Prolee you are so negative on this stock yet you want to buy in at some point? If I didn't believe in the company, staff and products I wouldn't ever invest regardless of the price. You make no sense.
I'm not being funny Prolee but no one's interested in what you've got to say so why not crawl back under your rock and only come back out IF and when a placing takes place. Then you can buy in which is what you really want to do now (but can't afford to) and invest with Trevor who by your own admission is clever.
If our covid test was used at Heathrow airport where approxiately 80 million use it annuallly and we made 20p per cartridge (being conservative) that would be £16 million profit in just one year. Now imagine if we did more than one airport? A fast and accurate test would be ideal and okay no one knows what the future holds but the potential is unreal.
and testing starts before the end of February for 10 days. If this proves to be true then the asking price for Paraytec goes up or if we go it alone the end product will be more in demand and we can ask for more ££££. Why sell the product or company now when there is every chance the end product could be worth so much more in a matter of days?
Well exactly sixs months ago today we raised £2.5 million through a placing at 18p. We were told then that the money would be used to fast track the covid test and to find a commercial partner if Paraytec is not sold outright. We were also told if this doesn't happen we would have sufficient fund to go it alone. Don't see what has changed apart from the usual negative posters (mention no names).
wookiemonster - you asked about how sepsis test is going so here's the last update from 21st January.Paraytec's programme to develop a test for bacteraemia, which causes sepsis, is continuing to make progress. This test will be based on Paraytec's the CX300 platform technology that was first developed for the COVID-19 test. The key to for the Bacteraemia Underpinning Sepsis (BuS) test is the building of a suite of specific macromolecules, each of which uniquely identifies one of the strains of bacteria known to cause sepsis. The work programme, now underway, involves the use of molecular biology to generate a library of one thousand billion different macromolecular structures. Synthetic virus particles will be tested for their affinity to the target bacterial strain and selected for their ability to bind tightly to bacterial surface molecules and be subsequently recovered from them. This selection process will be undertaken repeatedly to allow for the selection of a macromolecule with optimised binding properties. The precise molecular nature of the selected affinity macromolecule can be determined by sequencing the genome of the virus particle that has the desired bacterial surface binding properties. Work has started on the construction of the macromolecular library, together with the selection of preferred bacterial surface proteins, prior to the initiation of the selection process.
No hard feelings wookiemonster - but when you post for the first time on a board and claim to have held and sold on a spike it doesn't look good that's all.
What makes you think we've missed the boat with covid? Sepsis is looking great, as is covid with lots of news now and the end of the month.
wookiemonster - Well done for selling on a spike. If we knew any more on the sepsis test then we wouldn't be where we are now.
How's COPL going? It's currently 34p and the other day you were claining it's worth £3.
There was definitely a big seller around yesterday but personally I think that is down to NCYT falling over 20%, which if you are not already aware I believe there one of the biggest and most successful UK covid stocks out there. I read something on there forum where management said covid profits could or will fall by 50%.i Obviously if you are in both stocks then you will probably sell both f you heard that? Today I think is a follow on from yesterday followed by bargain buying towards the end of the day. Also BRH is not just about covid so definitely oversold in my opinion.
If they decide to go it alone with Paraytec then surely they can use the proceeds from the sale of PhaseFocus which is imminent - told within the next 12 months in the half year report on 15th November. And surely if they do need more money then they must have orders to fill otherwise what other reason could there be? IMO I just think covid stocks are out of favour at the moment -look at GDR, ODX, ACTA but that doesn't mean to say it will stay that way and as Trevor said in his video we all need to find a post covid normal.